We subcutaneously inoculated wild‐type B16 (B16‐WT) and mitophagy‐deficient B16 cancer cells (B16‐Parkin‐knockout) into immunocompetent C57 mice (Figure S6G, Supporting Information). This evidence concerns the gene PRKN and cancer.